NEW HAVEN, Conn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the launch of a new version of its Bloodhound MPN (Myeloproliferative ...
A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results